Vaccine Development

Many Paths Exist for Licensing Vaccine

Published in Medical Letter on the CDC and FDA, November 29th, 1999

by Salynn Boyles -- There are many paths to licensing a vaccine in the United States, according to a U.S. Centers for Disease Control and Prevention (CDC) report.

Researcher G. Peter and colleagues from the CDC's National Advisory Committee warned that the U.S. vaccine development network must be closely monitored in the future to ensure the safety and efficacy of new vaccines aimed at populations in America and globally ("Lessons Learned from a Review of the Development of Selected Vaccines," Pediatrics, October 1999;104(4):942-950).

"Although the vaccine research and development network in the United States remains vibrant, its continued success...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (1999-11-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry